Pain, Muscle
7
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Depo-Medrol on Psoas After LLIF
Essential Oils Following IUD Insertion
Erector Spina Plane Block and Radiofrequency Treatmen
Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)
Arnica and the Management of Pain in Acute Musculoskeletal Extremity Injuries
Modulation of an Experimental Prolonged Pain Model Using High Definition Transcranial Direct Current Stimulation
Temporal Relationship in Recovery of Muscular Pain and Functional Variables in an Experimental Muscular Pain Model in Hamstrings